BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17679129)

  • 1. Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
    Fang MC; Go AS; Chang Y; Hylek EM; Henault LE; Jensvold NG; Singer DE
    Am J Med; 2007 Aug; 120(8):700-5. PubMed ID: 17679129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.
    Fang MC; Go AS; Hylek EM; Chang Y; Henault LE; Jensvold NG; Singer DE
    J Am Geriatr Soc; 2006 Aug; 54(8):1231-6. PubMed ID: 16913990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.
    Pappas MA; Barnes GD; Vijan S
    J Gen Intern Med; 2017 Apr; 32(4):464-470. PubMed ID: 28120297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
    Nielsen PB; Larsen TB; Skjøth F; Lip GY
    JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
    Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
    Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.
    Björck S; Palaszewski B; Friberg L; Bergfeldt L
    Stroke; 2013 Nov; 44(11):3103-8. PubMed ID: 23982711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).
    Ashburner JM; Go AS; Reynolds K; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
    Am J Cardiol; 2015 Jan; 115(1):40-6. PubMed ID: 25456871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study.
    Cressman AM; Macdonald EM; Yao Z; Austin PC; Gomes T; Paterson JM; Kapral MK; Mamdani MM; Juurlink DN;
    Am Heart J; 2015 Jul; 170(1):133-40, 140.e1-3. PubMed ID: 26093874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin.
    Schauer DP; Moomaw CJ; Wess M; Webb T; Eckman MH
    J Gen Intern Med; 2005 Dec; 20(12):1114-9. PubMed ID: 16423100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
    Fang MC; Chang Y; Hylek EM; Rosand J; Greenberg SM; Go AS; Singer DE
    Ann Intern Med; 2004 Nov; 141(10):745-52. PubMed ID: 15545674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Held C; Hylek EM; Alexander JH; Hanna M; Lopes RD; Wojdyla DM; Thomas L; Al-Khalidi H; Alings M; Xavier D; Ansell J; Goto S; Ruzyllo W; Rosenqvist M; Verheugt FW; Zhu J; Granger CB; Wallentin L
    Eur Heart J; 2015 May; 36(20):1264-72. PubMed ID: 25499871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of anticoagulation resumption following traumatic brain injury.
    Albrecht JS; Liu X; Baumgarten M; Langenberg P; Rattinger GB; Smith GS; Gambert SR; Gottlieb SS; Zuckerman IH
    JAMA Intern Med; 2014 Aug; 174(8):1244-51. PubMed ID: 24915005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage.
    Rosand J; Eckman MH; Knudsen KA; Singer DE; Greenberg SM
    Arch Intern Med; 2004 Apr; 164(8):880-4. PubMed ID: 15111374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.